Pfizer
PFE
PFE
2,045 hedge funds and large institutions have $140B invested in Pfizer in 2017 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 813 increasing their positions, 909 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9% less funds holding in top 10
Funds holding in top 10: 179 → 162 (-17)
11% less repeat investments, than reductions
Existing positions increased: 813 | Existing positions reduced: 909
12% less call options, than puts
Call options by funds: $1.09B | Put options by funds: $1.24B
Holders
2,045
Holding in Top 10
162
Calls
$1.09B
Puts
$1.24B
Top Buyers
| 1 | +$314M | |
| 2 | +$310M | |
| 3 | +$268M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$257M |
| 5 |
Goldman Sachs
New York
|
+$217M |
Top Sellers
| 1 | -$459M | |
| 2 | -$419M | |
| 3 | -$372M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$329M |
| 5 |
Bank of New York Mellon
New York
|
-$195M |